Clinical Trials Logo

Acinetobacter Bacteraemia clinical trials

View clinical trials related to Acinetobacter Bacteraemia.

Filter by:
  • None
  • Page 1

NCT ID: NCT01511224 Recruiting - Clinical trials for Acinetobacter Bacteraemia

A Prospective Observational Study of Patients With Drug Resistant Acinetobacter Baumannii Bacteremia

Start date: August 2010
Phase: N/A
Study type: Observational

Extensively and multi-drug resistant A. baumannii (AB) represent an emerging threat in hospitals locally and worldwide. There is lack of prospective comparative clinical data to guide optimal strategy for treating such infections. Since it remains unclear how to treat bacteremia caused by AB, the present study aims to enroll patients at multiple sites with extensively drug resistant Acinetobacter species bacteremia receiving different combination therapy to assess treatment outcomes and analyze risk factors associated with mortality.

NCT ID: NCT01374256 Not yet recruiting - Clinical trials for Acinetobacter Bacteraemia

Imipenem and Sulbactam in the Treatment of Imipenem-resistant Acinetobacter Baumannii Bacteremia

Start date: July 2011
Phase: N/A
Study type: Observational

Infections caused by imipenem-resistant Acinetobacter baumannii are associated with high mortality and morbidity. The treatment choices for this resistant pathogen are limited. The objective of the present proposal is to evaluate the effectiveness of combination therapy of imipenem and sulbactam in patients contracted with A. baumannii, and to correlate the clinical effect with the in vitro synergistic results.